Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.
about
Dysregulation of antiviral helicase pathways in systemic lupus erythematosusIdentification of Candidate Predictors of Lupus FlareTLRs and interferons: a central paradigm in autoimmunityLGP2 synergy with MDA5 in RLR-mediated RNA recognition and antiviral signalingAdvances in lupus geneticsIRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosusAdmixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody productionGenetics of systemic lupus erythematosus: immune responses and end organ resistance to damage.Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.Type I interferon in the pathogenesis of lupus.Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosusSLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signatureGenetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Interferon regulatory factors: critical mediators of human lupus.Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5MDA5-filament, dynamics and disease.The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.Metagenomics and personalized medicine.Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus.Immunogenetics of systemic lupus erythematosus: A comprehensive review.The genetics of lupus: a functional perspective.Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis.Genetics of Lupus Nephritis: Clinical Implications.The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.The new perspectives on genetic studies of type 2 diabetes and thyroid diseasesIncreased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations.Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.Familial aggregation of high tumor necrosis factor alpha levels in systemic lupus erythematosus.Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.Genetics of the type I interferon pathway in systemic lupus erythematosus.Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patientsImmunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes.Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.The genetics of innate immunity sensors and human disease.Association of IFIH1 rs1990760 polymorphism with susceptibility to autoimmune diseases: a meta-analysis.Antiviral RNA recognition and assembly by RLR family innate immune sensors.Immune sensing of nucleic acids in inflammatory skin diseases.Genetic variation in pattern recognition receptors: functional consequences and susceptibility to infectious disease.Systemic Lupus Erythematosus--A Disease with A Dysregulated Type I Interferon System.
P2860
Q21129494-4962168A-2186-4798-958C-3F8BD91F9B37Q26795372-53CA7B23-6EB6-45A0-AD16-67056F85542EQ27023982-122A9767-735B-4DC0-B355-393AF45B82A4Q28084011-9E91137B-44EC-40C9-9CF3-53B3CA4F699FQ28088718-2A9999E3-0B5E-4F1A-AAA3-872EF96724B1Q28253129-958A9A55-B840-4B32-A528-85EB2C98DD92Q28486228-06639D03-96B7-449A-B5C3-AAB0FF91DA9AQ30301191-79CE283D-A531-4B58-A582-0A7817A690A4Q33398517-65969678-8FF2-4297-A134-5405B0418D4CQ33777950-DCCC2CCA-020D-4141-877F-82F4B839D385Q33852174-70CB4017-A4E6-40DE-B0B5-0D16C6AF51F6Q34064253-0257F51E-1A3C-41B3-B32F-8DCD24D501C3Q34796327-15C653FF-BAF5-44B3-BD7F-1B208352AD4BQ35008001-DAABDD8F-A251-4F1B-814C-21BEA556D330Q35014051-3B58DC17-B9C0-4E00-BAFC-D291D228A9EDQ35716846-813E00F3-9BBF-4521-88AA-90545E190A5CQ35751893-9CFC7220-4B25-43C6-859A-CAC06DBA8465Q35832505-59F22547-09AB-4D50-8906-F259EE7F3B78Q36202077-ED644740-FFC4-45CD-857F-A0E3122E4DA8Q36228760-841DC943-7172-4839-8635-C35F2A6D776DQ36236807-904002FB-E9D8-43AA-985F-49985FC8E924Q36245989-85805BD9-95CC-4886-8058-73CC6D45F070Q36289499-7A84B256-47F1-43BF-B38E-80E21A8389E7Q36300008-C225ACE7-A557-40A7-8318-B4D9FC988D66Q36338717-F344E254-5FFC-48C3-977B-0C43924BDD57Q36634117-1DC85AEF-B779-4C09-B02A-29243D7B7DC2Q37103639-EBEDB450-0532-4E7D-9924-C2803CA134FAQ37208233-747DB3C6-92FD-4C34-AF2C-2B53AC697254Q37239812-0ED17262-E3FC-43DB-9972-30FB5854570BQ37375806-022B24EC-F9BD-458D-90F3-B5E8E522A81EQ37450879-B9241927-3BC3-48AB-A710-6D06D520D35DQ37543386-4F2C6E58-5272-4B47-B39A-7FFAD7B7AC53Q37990026-4E9570A1-F058-4B63-AD70-B3799178FB33Q38068405-C5CB36E4-EE38-44B1-91F5-68D3325094C9Q38097500-A27C25D3-AA19-4384-9F84-DF973668C88AQ38111804-1B126A1E-0585-43E5-A537-814D3488A31BQ38235759-3AF0976A-C13D-4AD8-99DB-1A7BC26B6D65Q38249899-DDB6EE0F-B7BF-44F1-9533-DB71DF6CE710Q38522796-A57ED2C3-5F72-40EA-9F99-80E361CD34B3Q38534457-8B2EDB5E-1BDB-4075-AAD4-CAE024FB2F66
P2860
Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Autoimmune disease risk varian ...... utoimmunity in lupus patients.
@ast
Autoimmune disease risk varian ...... utoimmunity in lupus patients.
@en
type
label
Autoimmune disease risk varian ...... utoimmunity in lupus patients.
@ast
Autoimmune disease risk varian ...... utoimmunity in lupus patients.
@en
prefLabel
Autoimmune disease risk varian ...... utoimmunity in lupus patients.
@ast
Autoimmune disease risk varian ...... utoimmunity in lupus patients.
@en
P2093
P2860
P356
P1476
Autoimmune disease risk varian ...... utoimmunity in lupus patients.
@en
P2093
Akaash A Kumar
Barbara E Drevlow
Beverly S Franek
Galen Guerrero
James S Grober
Kyriakos A Kirou
Laura S Zaacks
Lewis M Cohen
Maria Badaracco
Marissa Kumabe
P2860
P304
P356
10.4049/JIMMUNOL.1100857
P407
P577
2011-06-24T00:00:00Z